• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO CARDINAL HEALTH RAPID TEST HCG CASSETTE; HCG PREGNANCY TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO CARDINAL HEALTH RAPID TEST HCG CASSETTE; HCG PREGNANCY TEST Back to Search Results
Model Number FHC-102
Device Problem False Negative Result (1225)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/27/2019
Event Type  malfunction  
Manufacturer Narrative
Results pending completion of investigation.
 
Event Description
The customer reported that on (b)(6) 2019, an hcg rapid test was administered using a urine sample which produced a false negative result.The beta serum quant result was 143 miu/ml and an ultrasound confirmed pregnancy.The patient was not provided/withheld treatment nor were there changes in medication due to the hcg results.
 
Manufacturer Narrative
Update to d4: udi number corrected.Investigation conclusion: an investigation was performed on retained devices from the reported lot number.Retained devices were tested with qc cut-off standard (25 miu/ml) and middle positive standard (100 miu/ml).Results were read at 3 minutes and all devices produced expected positive results.No false negative results were observed during in-house testing.The case details were reviewed along with the complaint history for the reported issue and no indications of a systemic issue were identified.Batch record review found no relevant non-conformances; the lot met all final release specifications.Review of the risk management report for this product found that the reported issue is within the risk profile for this device; no new hazard has been identified.It was reported that 3-4 drops of the patient urine sample was transferred to the test.Per the package insert, transfer 3 full drops of urine (approx.100 ul) to the specimen well of the test cassette.No further deviations regarding product storage and testing technique were observed.The reported issue was not replicated as retention product performed as expected.A probable cause could not be determined based on the information available.As stated in the product insert, a first morning urine specimen is preferred since it generally contains the highest concentration of hcg; however, urine specimens collected at any time of the day may be used.Urine specimens exhibiting visible precipitates should be centrifuged, filtered, or allowed to settle to obtain a clear specimen for testing.Very dilute urine specimens, as indicated by a low specific gravity, may not contain representative levels of hcg.False negative results may occur when the levels of hcg are below the sensitivity level of the test.When pregnancy is still suspected, a first morning urine specimen should be collected 48 hours later and tested.This test provides a presumptive diagnosis for pregnancy.A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
 
Manufacturer Narrative
Update to section d10: date return was received by investigator was 17 dec 2019.Investigation conclusion: an investigation was performed on retention and returned products from the reported lot number.Retention and returned devices were tested with qc cut-off standard (25 miu/ml) and middle positive standard (100 miu/ml).Results were read at 3 minutes and all devices produced expected positive results.No false negative results were observed during in-house testing.The case details were reviewed along with the complaint history for the reported issue and no indications of a systemic issue were identified.Batch record review found no relevant non-conformances; the lot met all final release specifications.Review of the risk management report for this product found that the reported issue is within the risk profile for this device; no new hazard has been identified.It was reported that 3-4 drops of the patient urine sample was transferred to the test.Per the package insert, transfer 3 full drops of urine (approx.100 ul) to the specimen well of the test cassette.No further deviations regarding product storage and testing technique were observed.The reported issue was not replicated as retention product performed as expected.A probable cause could not be determined based on the information available.Per the product insert, a first morning urine specimen is preferred since it generally contains the highest concentration of hcg; however, urine specimens collected at any time of the day may be used.Urine specimens exhibiting visible precipitates should be centrifuged, filtered, or allowed to settle to obtain a clear specimen for testing.Very dilute urine specimens, as indicated by a low specific gravity, may not contain representative levels of hcg.False negative results may occur when the levels of hcg are below the sensitivity level of the test.When pregnancy is still suspected, a first morning urine specimen should be collected 48 hours later and tested.This test provides a presumptive diagnosis for pregnancy.A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARDINAL HEALTH RAPID TEST HCG CASSETTE
Type of Device
HCG PREGNANCY TEST
Manufacturer (Section D)
ALERE SAN DIEGO
9995 summers ridge rd
san diego CA 92121
MDR Report Key9269317
MDR Text Key189217424
Report Number2027969-2019-00595
Device Sequence Number1
Product Code JHI
Combination Product (y/n)N
PMA/PMN Number
K993317
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Type of Report Initial,Followup,Followup
Report Date 01/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/01/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Model NumberFHC-102
Device Catalogue NumberB1077-22
Device Lot NumberHCG9030033
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/17/2019
Date Manufacturer Received01/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age23 YR
-
-